相关实验视频
Updated: Mar 24, 2026

15:48
ALS - Motor Neuron Disease: Mechanism and Development of New Therapies
Published on: July 29, 2007
10.1K
前性痴呆-运动神经元疾病连续性
James R Burrell1, Glenda M Halliday1, Jillian J Kril2
1Neuroscience Research Australia, Sydney, NSW, Australia; Faculty of Medicine, University of New South Wales, Sydney, NSW, Australia.
Lancet (London, England)
|March 19, 2016
概括
前性痴呆运动神经元疾病 (FTD-MND) 是一种已知的痴呆症候群. 重叠的TDP-43病理和C9orf72重复扩张是关键特征,为病变发生和潜在治疗提供了洞察力.
科学领域:
- 神经学
- 神经科学
- 遗传学
背景情况:
- 运动神经元疾病 (MND) 越来越多地被认为包括认知和行为缺陷.
- 前性痴呆-运动神经元疾病 (FTD-MND) 连续性的概念在过去十年中得到了突出地位.
- FTD-MND是一种严重的痴呆症候群,具有诊断和管理方面的挑战.
研究的目的:
- 审查目前对FTD-MND连续性的理解.
- 突出共同的病理特征和遗传基础.
- 讨论对诊断,病变和治疗目标的影响.
主要方法:
- 对FTD-MND现有文献的审查.
- 分析常见的病理特征,包括TARDNA结合蛋白 (TDP-43) 的病理.
- 检查遗传因素,特别是9号染色体的开放阅读框架72 (C9orf72) 重复扩张.
主要成果:
- FTD,MND和FTD-MND共享重叠的TDP-43蛋白质病变模式.
- 在FTD-MND频谱中,C9orf72的重复扩展是普遍存在的.
- 这种基因扩展为疾病机制和潜在治疗途径提供了关键的洞察力.
结论:
- FTD-MND是一个重要的痴呆症候群,需要进一步的临床定义.
- 共同的病理和遗传突显了FTD和MND之间的连续性.
- 了解这些共同点对于推进诊断和开发向治疗至关重要.
相关概念视频
Parkinson's Disease: Overview
2.3K
Neurodegenerative disorders are progressive diseases that cause irreversible damage and loss to neurons in specific brain areas. Examples of these disorders include Parkinson's disease, Alzheimer's disease, Multiple Sclerosis (MS), and Amyotrophic Lateral Sclerosis (ALS). These disorders share characteristics such as proteinopathies, selective neuronal vulnerability, and a complex interplay between genetic and environmental factors. The primary therapeutic goal for these conditions is...
2.3K
Alzheimer's Disease: Overview
2.0K
Alzheimer's Disease (AD) is a continually advancing neurodegenerative disorder, distinguished by escalating memory loss, cognitive dysfunction, and dementia. The disease unfolds in three stages: preclinical, mild cognitive impairment (MCI), and dementia. Its onset is insidious, and the progression gradual, with the cause not well explained by other disorders.
The clinical diagnosis of AD hinges on the presence of memory and other cognitive impairments. Biomarkers, such as changes in Aβ...
The clinical diagnosis of AD hinges on the presence of memory and other cognitive impairments. Biomarkers, such as changes in Aβ...
2.0K
Dementia
672
Dementia is a collective term for cognitive disorders primarily affecting memory, thinking, and reasoning. It is not a specific disease but a syndrome, with Alzheimer's disease being the most common cause, accounting for approximately 60-80% of cases. Other types include vascular dementia, Lewy body dementia, and frontotemporal dementia. Dementia affects millions worldwide, particularly older adults, though it is not a normal part of aging.
The progression of dementia is generally gradual....
The progression of dementia is generally gradual....
672
Direct Motor Pathways
5.1K
The direct motor pathways, also known as the pyramidal tracts, are a group of neural pathways that originate in the brain and descend through the spinal cord. They control the voluntary movement of the body. There are two major direct motor pathways: the corticospinal and the corticobulbar tracts.
The corticospinal tract is responsible for the voluntary movement of the limbs and trunk. It originates in the cerebral cortex of the brain and descends through the cerebrum's internal capsule and...
The corticospinal tract is responsible for the voluntary movement of the limbs and trunk. It originates in the cerebral cortex of the brain and descends through the cerebrum's internal capsule and...
5.1K
Disorders of the Nervous Tissue
3.0K
Nervous tissue is a vital component of the human body's communication system, enabling us to perceive and respond to stimuli. However, like all other tissues, it is vulnerable to disorders and diseases that can significantly impact our neurological functioning.
Homeostatic Imbalances:
Alzheimer's disease manifests as a gradual decline in memory and cognitive abilities, attributed to the buildup of amyloid plaques and neurofibrillary tangles in the brain.
Parkinson's disease arises from the...
Homeostatic Imbalances:
Alzheimer's disease manifests as a gradual decline in memory and cognitive abilities, attributed to the buildup of amyloid plaques and neurofibrillary tangles in the brain.
Parkinson's disease arises from the...
3.0K
Alzheimer's Disease: Treatment
1.2K
Alzheimer's Disease (AD), a neurodegenerative disorder, is pathologically identified by amyloid plaques and neurofibrillary tangles composed of tau protein. AD pharmacotherapy aims to manage cognitive symptoms, delay disease progression, and treat behavioral symptoms. The treatment is primarily symptomatic and palliative, with no definitive disease-modifying therapy available. Cholinesterase inhibitors, including donepezil (Aricept), rivastigmine (Exelon), and galantamine (Razadyne), are...
1.2K

